| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 2 | -263,192 | 100% | $22.99 | -$6,051,542 |
| Net | -2 | -263,192 | -100% | -$6,051,542 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Alan Leonard Smith | IVZ | Common Shares | Tax liability | -21% | -3,849 | 14,489 | 13 Mar 2026 | Direct | ||
| Alan Leonard Smith | IVZ | Common Shares | Award | 89.1% | 8,641 | 18,338 | 13 Mar 2026 | Direct | ||
| Alan Leonard Smith | IVZ | Restricted Stock Units | Options Exercise | -50% | -8,641 | 8,641 | 13 Mar 2026 | Direct | ||
| Terry Vacheron | IVZ | Common Shares | Tax liability | -12.7% | -2,852 | 19,569 | 28 Feb 2026 | Direct | ||
| Terry Vacheron | IVZ | Common Shares | Award | 27.2% | 4,798 | 22,421 | 28 Feb 2026 | Direct | ||
| Terry Vacheron | IVZ | Restricted Stock Units | Award | 8,187 | 8,187 | 28 Feb 2026 | Direct | |||
| Terry Vacheron | IVZ | Restricted Stock Units | Options Exercise | -48.6% | -4,798 | 5,069 | 28 Feb 2026 | Direct | ||
| Alan Leonard Smith | IVZ | Common Shares | Tax liability | -29.3% | -4,014 | 9,697 | 28 Feb 2026 | Direct | ||
| Alan Leonard Smith | IVZ | Common Shares | Award | 187.1% | 8,936 | 13,711 | 28 Feb 2026 | Direct | ||
| Alan Leonard Smith | IVZ | Restricted Stock Units | Award | 32,202 | 32,202 | 28 Feb 2026 | Direct | |||
| Alan Leonard Smith | IVZ | Restricted Stock Units | Options Exercise | -25% | -8,936 | 26,808 | 28 Feb 2026 | Direct | ||
| Douglas J. Sharp | IVZ | Common Shares | Tax liability | -35.1% | -21,685 | 40,115 | 28 Feb 2026 | Direct | ||
| Douglas J. Sharp | IVZ | Common Shares | Award | 294.6% | 46,138 | 61,800 | 28 Feb 2026 | Direct | ||
| Douglas J. Sharp | IVZ | Restricted Stock Units | Award | 80,969 | 80,969 | 28 Feb 2026 | Direct | |||
| Andrew Schlossberg | IVZ | Common Shares | Tax liability | -9.47% | -94,002 | 898,715 | 28 Feb 2026 | Direct | ||
| Andrew Schlossberg | IVZ | Common Shares | Award | 21.9% | 178,634 | 992,717 | 28 Feb 2026 | Direct | ||
| Andrew Schlossberg | IVZ | Restricted Stock Units | Award | 189,127 | 189,127 | 28 Feb 2026 | Direct | |||
| Andrew Schlossberg | IVZ | Restricted Stock Units | Options Exercise | -53.3% | -97,664 | 85,497 | 28 Feb 2026 | Direct | ||
| Andrew Tak Shing Lo | IVZ | Common Shares | Award | 21.8% | 150,267 | 839,093 | 28 Feb 2026 | Direct | ||
| Andrew Tak Shing Lo | IVZ | Restricted Stock Units | Award | 77,370 | 77,370 | 28 Feb 2026 | Direct | |||
| Andrew Tak Shing Lo | IVZ | Restricted Stock Units | Options Exercise | -100% | -66,848 | 0 | 28 Feb 2026 | Direct | ||
| Jeffrey H. Kupor | IVZ | Common Shares | Tax liability | -4.49% | -7,130 | 151,820 | 28 Feb 2026 | Direct | ||
| Jeffrey H. Kupor | IVZ | Common Shares | Award | 7.54% | 11,143 | 158,950 | 28 Feb 2026 | Direct | ||
| Jeffrey H. Kupor | IVZ | Restricted Stock Units | Award | 35,343 | 35,343 | 28 Feb 2026 | Direct | |||
| Jeffrey H. Kupor | IVZ | Restricted Stock Units | Options Exercise | -52.7% | -11,143 | 10,007 | 28 Feb 2026 | Direct | ||
| Shannon A. Johnston | IVZ | Common Shares | Tax liability | -13.8% | -3,970 | 24,846 | 28 Feb 2026 | Direct | ||
| Shannon A. Johnston | IVZ | Common Shares | Award | 44.8% | 8,913 | 28,816 | 28 Feb 2026 | Direct | ||
| Shannon A. Johnston | IVZ | Restricted Stock Units | Award | 37,825 | 37,825 | 28 Feb 2026 | Direct | |||
| Shannon A. Johnston | IVZ | Restricted Stock Units | Options Exercise | -25% | -8,913 | 26,739 | 28 Feb 2026 | Direct | ||
| Laura Allison Dukes | IVZ | Common Shares | Tax liability | -14.5% | -58,064 | 342,261 | 28 Feb 2026 | Direct | ||
| Laura Allison Dukes | IVZ | Common Shares | Award | 36.6% | 107,152 | 400,325 | 28 Feb 2026 | Direct | ||
| Laura Allison Dukes | IVZ | Restricted Stock Units | Award | 73,257 | 73,257 | 28 Feb 2026 | Direct | |||
| Laura Allison Dukes | IVZ | Restricted Stock Units | Options Exercise | -55.5% | -44,021 | 35,317 | 28 Feb 2026 | Direct | ||
| Stephanie Butcher | IVZ | Common Shares | Tax liability | -30.9% | -9,237 | 20,618 | 28 Feb 2026 | Direct | ||
| Stephanie Butcher | IVZ | Restricted Stock Units | Award | 66,317 | 66,317 | 28 Feb 2026 | Direct | |||
| Tony Wong | IVZ | Common Shares | Tax liability | -12.3% | -17,854 | 126,971 | 28 Feb 2026 | Direct | ||
| Tony Wong | IVZ | Common Shares | Award | 28.3% | 31,955 | 144,825 | 28 Feb 2026 | Direct | ||
| Tony Wong | IVZ | Restricted Stock Units | Award | 66,317 | 66,317 | 28 Feb 2026 | Direct | |||
| Tony Wong | IVZ | Restricted Stock Units | Options Exercise | -51% | -31,955 | 30,687 | 28 Feb 2026 | Direct | ||
| Tony Wong | IVZ | Common Shares | Tax liability | -26.2% | -40,113 | 112,870 | 06 Feb 2026 | Direct | ||
| Douglas J. Sharp | IVZ | Common Shares | Tax liability | -46.7% | -13,719 | 15,662 | 15 Jan 2026 | Direct | ||
| Douglas J. Sharp | IVZ | Common Shares | Award | 15202.6% | 29,189 | 29,381 | 15 Jan 2026 | Direct | ||
| Douglas J. Sharp | IVZ | Restricted Stock Units | Options Exercise | -33.3% | -29,189 | 58,377 | 15 Jan 2026 | Direct | ||
| Andrew Schlossberg | IVZ | Common Shares | Gift | -2.26% | -18,800 | 814,083 | 11 Dec 2025 | Direct | ||
| Douglas J. Sharp | IVZ | Common Shares | Sale | -99.9% | $3,768,832 | $23.56 | -160,000 | 192 | 31 Oct 2025 | Direct |
| Shannon A. Johnston | IVZ | Common Shares | Tax liability | -29.5% | -8,345 | 19,903 | 16 Oct 2025 | Direct | ||
| Shannon A. Johnston | IVZ | Common Shares | Award | 28,248 | 28,248 | 16 Oct 2025 | Direct | |||
| Shannon A. Johnston | IVZ | Restricted Stock Units | Options Exercise | -25% | -28,248 | 84,746 | 16 Oct 2025 | Direct | ||
| Stephanie Butcher | IVZ | Common Shares | Sale | -77.6% | $2,282,710 | $22.12 | -103,192 | 29,855 | 10 Sep 2025 | Direct |
| Douglas J. Sharp | IVZ | Common Shares | Tax liability | -16.5% | -26,591 | 134,837 | 31 Aug 2025 | Direct |